Note: Ingredients listed on restricted chemical lists
EC/CAS
125116-23-6
Name of the chemical
Metconazol (ISO); (1RS,5RS;1RS,5SR)-5-(4-Chlorbenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol (790/2009)
Concentration
8.6
General Information
Version
1.0
Revision date
2023-10-25
Product name
TURRET
1.2.1 Relevant identified uses
Industrial/Professional use spec
Emergency telephone
0344 892 0111, +44 20 7188 7188
Icons in SDS
Company Information
company name
Globachem N.V
e-mail address of the competent person responsible for the Safety Data Sheet
msds@globachem.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319, H361d, H412
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Hazard pictograms
GHS07 GHS08
Signal word
Warning
Contains
metconazole (ISO); (1RS, 5RS; 1RS, 5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4- triazol-1-ylmethyl)cyclopentanol
Hazard statements
H319 - Causes serious eye irritation. H361d - Suspected of damaging the unborn child. H412 - Harmful to aquatic life with long lasting effects.
Precautionary statements
P201 - Obtain special instructions before use. P280 - Wear protective gloves, protective clothing, eye protection. P308+P311 - IF exposed or concerned: Call a POISON CENTER, doctor. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P405 - Store locked up. P501 - Dispose of contents and container to a licensed hazardous-waste disposal contractor or collection site.
Supplemental label elements
EUH401 - To avoid risks to human health and the environment, comply with the instructions for use.
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %